Brainsway (BWAY) Change in Receivables (2018 - 2026)
Brainsway (BWAY) posted quarterly Change in Receivables of -$3.5 million for Q1 2026, down 47.08% year-on-year from -$6.5 million in Q1 2025, and down 436.74% on a QoQ basis from $1.0 million in Q4 2025.
Brainsway (BWAY) Change in Receivables (2018 - 2026) Analysis & Trends
Brainsway (BWAY) has reported Change in Receivables for 9 consecutive years, with -$3.5 million the latest figure, recorded in Q1 2026.
- Quarterly Change in Receivables fell 47.08% year-over-year to -$3.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$499000.0 (up 81.11% YoY) and the FY2025 annual result came in at $607000.0, up 170.01% from the prior year.
- Change in Receivables declined to -$3.5 million in Q1 2026 per BWAY's latest filing, from $1.0 million in the prior quarter.
- Over the last five years, Change in Receivables for BWAY reached as high as $3.2 million in Q2 2025 and fell as low as -$3.5 million in Q1 2026.
- A 5-year average of -$68823.5 and a median of -$63000.0 in 2022 frame the typical range for Change in Receivables.
- Annual changes were most pronounced in 2022 — Change in Receivables tumbled 2721.05% — and 2024, when it surged 1438.71%.
- Year by year, Change in Receivables stood at $821000.0 in 2022, then slumped by 138.37% to -$315000.0 in 2023, then tumbled by 268.89% to -$1.2 million in 2024, then surged by 188.3% to $1.0 million in 2025, then plunged by 436.74% to -$3.5 million in 2026.
- According to Business Quant data, Change in Receivables over the past three periods registered -$3.5 million, $1.0 million, and -$1.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 42.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -444.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 287.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 117.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 117.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | -124.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -141.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Brainsway | 646.63 Mn | 587.74 Mn | 11.68 Mn | -3.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.46 Mn |
| Mar 31, 2026 | -3.46 Mn |
| Dec 31, 2025 | 1.03 Mn |
| Dec 31, 2025 | 1.03 Mn |
| Sep 30, 2025 | -1.25 Mn |
| Sep 30, 2025 | -1.25 Mn |
| Jun 30, 2025 | 3.18 Mn |
| Jun 30, 2025 | 3.18 Mn |
| Mar 31, 2025 | -2.35 Mn |
| Mar 31, 2025 | -2.35 Mn |
| Dec 31, 2024 | -1.16 Mn |
| Dec 31, 2024 | -1.16 Mn |
| Sep 30, 2024 | 415,000.00 |
| Sep 30, 2024 | 415,000.00 |
| Jun 30, 2024 | 454,000.00 |
| Jun 30, 2024 | 454,000.00 |
| Mar 31, 2024 | -574,000.00 |
| Mar 31, 2024 | -574,000.00 |
| Dec 31, 2023 | -315,000.00 |
| Dec 31, 2023 | -315,000.00 |